Peter S. Knight

Peter S. Knight is a declared insider at 4 companies; the most frequent names are PAR Pharmaceutical Companies, Inc., bioAffinity Technologies, Inc. and Medicis Pharmaceutical Corp. We count 41 filings; the first trade dates from 1 July 2005 and the latest from 1 July 2024.

Market trades split into 3 purchases (€31k) and 14 sales (€1.2M). No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 17 share grants and 5 option exercises.

The record was last updated on 2 July 2024 with a share grant in bioAffinity Technologies, Inc. The most recent open-market purchase was published on 5 December 2022, 1,419 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.